Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Belotero Volume vs Belotero Volume Lidocaine for Chin Augmentation
DRKS00031802Phase 4Completed
- Sponsor
- Merz
- Start
- May 2023
- Modality
- Recombinant Proteins and Enzymes, Injectable Hydrogels → Hydrogel Systems → Drug Delivery Systems, Implantable Devices → Device-based Delivery → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of belotero and Belotero Volume Lidocaine in chin augmentation (2 arms), sponsored by Merz. Started May 2023; status: completed.
02
Drugs
beloteroBelotero Volume Lidocaine
03
Conditions
chin augmentation
Beyond the preview
Go deeper on DRKS00031802.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on DRKS00031802.